These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24461904)

  • 41. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues.
    Waters V; Ratjen F
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):807-19. PubMed ID: 17140357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
    Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
    Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cystic fibrosis. Target population for lung transplantation in North America in the 1990s.
    Starnes VA; Lewiston N; Theodore J; Stoehr C; Stinson E; Shumway NE; Oyer PE
    J Thorac Cardiovasc Surg; 1992 May; 103(5):1008-14. PubMed ID: 1569753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current microbiological data on lower respiratory tract infection in cystic fibrosis. Part I: Isolated microorganisms and their clinical significance].
    Coman G; Petraru E; Dahorea C; Anton DT
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):580-7. PubMed ID: 23077957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient.
    Taylor JL; Palmer SM
    J Heart Lung Transplant; 2006 Aug; 25(8):985-8. PubMed ID: 16890122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should cystic fibrosis patients infected with Burkholderia cepacia complex be listed for lung transplantation?
    Olland A; Falcoz PE; Kessler R; Massard G
    Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):631-4. PubMed ID: 21920934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Question 13: Can we predict the need for lung transplantation in children with cystic fibrosis?
    Piper N; Bajic M; Selvadurai H; Robinson P; Zurynski Y; Fitzgerald DA
    Paediatr Respir Rev; 2019 Apr; 30():30-33. PubMed ID: 30987796
    [No Abstract]   [Full Text] [Related]  

  • 48. Lung infections in pediatric lung transplantation: experience in 49 cases.
    Metras D; Viard L; Kreitmann B; Riberi A; Pannetier-Mille A; Garbi O; Marti JY; Geigle P
    Eur J Cardiothorac Surg; 1999 Apr; 15(4):490-4; discussion 495. PubMed ID: 10371127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of panresistant bacteria in cystic fibrosis patients on lung transplant outcome.
    Aris RM; Gilligan PH; Neuringer IP; Gott KK; Rea J; Yankaskas JR
    Am J Respir Crit Care Med; 1997 May; 155(5):1699-704. PubMed ID: 9154879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Specific complications after lung transplantation for cystic fibrosis].
    Allard-Recoque C; Bertocchi M; Mornex JF
    Rev Pneumol Clin; 2002 Dec; 58(6 Pt 1):307-10. PubMed ID: 12545130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on non-cystic fibrosis bronchiectasis.
    Bilton D
    Curr Opin Pulm Med; 2008 Nov; 14(6):595-9. PubMed ID: 18812838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful lung transplantation in spite of cystic fibrosis-associated liver disease: a case series.
    Klima LD; Kowdley KV; Lewis SL; Wood DE; Aitken ML
    J Heart Lung Transplant; 1997 Sep; 16(9):934-8. PubMed ID: 9322144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection.
    Qvist T; Eickhardt S; Kragh KN; Andersen CB; Iversen M; Høiby N; Bjarnsholt T
    Eur Respir J; 2015 Dec; 46(6):1823-6. PubMed ID: 26493807
    [No Abstract]   [Full Text] [Related]  

  • 54. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence.
    Zaidi S; Elidemir O; Heinle JS; McKenzie ED; Schecter MG; Kaplan SL; Dishop MK; Kearney DL; Mallory GB
    Transpl Infect Dis; 2009 Jun; 11(3):243-8. PubMed ID: 19298240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microbiology of airway disease in a cohort of patients with cystic fibrosis.
    Lambiase A; Raia V; Del Pezzo M; Sepe A; Carnovale V; Rossano F
    BMC Infect Dis; 2006 Jan; 6():4. PubMed ID: 16405721
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Emerging cystic fibrosis pathogens and the microbiome.
    Mahenthiralingam E
    Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():13-5. PubMed ID: 24832700
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiology of Cystic Fibrosis Airway Disease.
    Blanchard AC; Waters VJ
    Semin Respir Crit Care Med; 2019 Dec; 40(6):727-736. PubMed ID: 31887768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of severe lower respiratory infections in patients with cystic fibrosis.
    Speert DP
    Semin Respir Infect; 1989 Dec; 4(4):266-71. PubMed ID: 2516638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical mycobacterial and fungal infections in cystic fibrosis.
    Whittaker LA; Teneback C
    Semin Respir Crit Care Med; 2009 Oct; 30(5):539-46. PubMed ID: 19760541
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung transplantation for advanced bronchiectasis.
    Hayes D; Meyer KC
    Semin Respir Crit Care Med; 2010 Apr; 31(2):123-38. PubMed ID: 20354926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.